CASTOR1 functional inactivation drives KRAS-mutant NSCLC and therapy resistance by a noncanonical mechanism of tumor suppression.
Overview & Synopsis
Open access biomedical research article published in Sci Adv.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | CASTOR1 functional inactivation drives KRAS-mutant NSCLC and therapy resistance by a noncanonical mechanism of tumor suppression. |
|---|---|
| Author / Organization | Wang X, Ding L, Meng W, Byrnes E, Loo SK, Sun S, Chen L, Li T, Wang MT, Pennathur A, Huang Y, Gao SJ |
| Subject & Discipline | Sci Adv |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-36781 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |